The endothelial glycocalyx in syndecan-1 deficient mice

Microvascular Research

Volumn 87, Issue , 2013, Pages 83-91

  Savery, Michele D ^a   Jiang, John X ^a   Park, Pyong Woo ^b   Damiano, Edward R ^a  

^a Boston University   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SYNDECAN 1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREMASTER MUSCLE; ENDOTHELIAL GLYCOCALYX; GLYCOCALYX; HYDRODYNAMICS; LEUKOCYTE ADHERENCE; MALE; MOUSE; NONHUMAN; PARTICLE IMAGE VELOCIMETRY; PRIORITY JOURNAL; THICKNESS; VASCULAR ENDOTHELIUM;

ANIMALS; BLOOD FLOW VELOCITY; CELL ADHESION; ENDOTHELIAL CELLS; GLYCOCALYX; HYDRODYNAMICS; LEAST-SQUARES ANALYSIS; LEUKOCYTES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, FLUORESCENCE; MICROSCOPY, VIDEO; NONLINEAR DYNAMICS; REGIONAL BLOOD FLOW; SYNDECAN-1; VENULES;

MUS;

EID: 84876320868     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2013.02.001     Document Type: Article

References (51)

1. Alexander C.M., Reichsman F., Hinkes M.T., Lincecum J., Becker K.A., Cumberledge S., Bernfield M. Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice. Nat. Genet. 2000, 25:329-332.
2. Alexopoulou A.N., Multhaupt H.A.B., Couchman J.R. Syndecans in wound healing, inflammation, and vascular biology. Int. J. Biochem. Cell Biol. 2007, 39:505-528.
3. Baez S. An open cremaster muscle preparation for the study of blood vessels by in vivo microscopy. Microvasc. Res. 1973, 5:384-394.
4. Barker A.L., Konopatskaya O., Neal C.R., Macpherson J.V., Whatmore J.L., Winlove P.C., Unwin P.R., Shore A.C. Observation and characterisation of the glycocalyx of viable human endothelial cells using confocal laser scanning microscopy. Phys. Chem. Chem. Phys. 2004, 6:1006-1011.
5. Bernfield M., Kokenyesi R., Kato M., Hinkes M.T., Spring J., Gallo R.L., Lose E.J. Biology of the syndecans: a family of transmembrane heparan-sulfate proteoglycans. Annu. Rev. Cell Biol. 1992, 8:365-393.
6. Bruegger D., Jacob M., Rehm M., Loetsch M., Welsch U., Conzen P., Becker B.F. Atrial natriuretic peptide induces shedding of the endothelial glycocalyx in coronary vascular bed of guinea pig hearts. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:H1993-H1999.
7. Chappell D., Jacob M., Hofmann-Kiefer K., Bruegger D., Rehm M., Conzen P., Welsch U., Becker B.F. Hydrocortisone preserves the vascular barrier by protecting the endothelial glycocalyx. Anesthesiology 2007, 107:776-784.
8. Chappell D., Westphal M., Jacob M. The impact of glycocalyx on microcirculatory oxygen distribution in critical illness. Curr. Opin. Anaesthesiol. 2009, 22:155-162.
9. Chappell D., Jacob M., Paul O., Rehm M., Welsch U., Stoekelhuber M., Conzen P., Becker B.F. The glycocalyx of the human umbilical vein endothelial cell: an impressive structure ex vivo but not in culture. Circ. Res. 2009, 104:1313-1317.
10. Damiano E.R., Stace T.M. A mechano-electrochemical model of radial deformation of the capillary glycocalyx. Biophys. J. 2002, 82:1153-1175.
11. Damiano E.R., Long D.S., El-Khatib F.H., Stace T.M. On the motion of a sphere in a Stokes flow parallel to a Brinkman half-space. J. Fluid Mech. 2004, 500:75-101.
12. Damiano E.R., Long D.S., Smith M.L. Estimation of viscosity profiles using velocimetry data from parallel flows of linearly viscous fluids: application to microvascular haemodynamics. J. Fluid Mech. 2004, 512:1-19.
13. Desjardins C., Duling B.R. Heparinase treatment suggests a role for the endothelial cell glycocalyx in regulation of capillary hematocrit. Am. J. Physiol. 1990, 258:H647-H654.
14. Floer M., Götte M., Wild M.K., Heidemann J., Gassar E.S., Domschke W., Kiesel L., Luegering A., Kucharzik T. Enoxaparin improves the course of dextran sodium sulfate-induced colitis in syndecan-1-deficient mice. Am. J. Pathol. 2010, 176:146-157.
15. Götte M., Joussen A.M., Klein C., Andre P., Wagner D.D., Hinkes M.T., Kirchhof B., Adamis A.P., Bernfield M. Role of syndecan-1 in leukocyte-endothelial interactions in the ocular vasculature. Investig. Ophthalmol. Vis. Sci. 2002, 43:1135-1141.
16. Götte M., Bernfield M., Joussen A.M. Increased leukocyte-endothelial interactions in syndecan-1-deficient mice involve heparan sulfate-dependent and -independent steps. Curr. Eye Res. 2005, 30:417-422.
17. Gretz J.E., Duling B.R. Measurement uncertainties associated with the use of bright-field and fluorescence microscopy in the microcirculation. Microvasc. Res. 1995, 49:134-140.
18. Hayashida K., Chen Y., Bartlett A.H., Park P.W. Syndecan-1 is an in vivo suppressor of Gram-positive toxic shock. J. Biol. Chem. 2008, 283:19895-19903.
19. Hayashida K., Parks W.C., Park P.W. Syndecan-1 shedding facilitates the resolution of neutrophilic inflammation by removing sequestered CXC chemokines. Blood 2009, 114:3033-3043.
20. Henry C.B., Duling B.R. Permeation of the luminal capillary glycocalyx is determined by hyaluronan. Am. J. Physiol. 1999, 277:H508-H514.
21. Hofmann-Kiefer K.F., Kemming G.I., Chappell D., Flondor M., Kisch-Wedel H., Hauser A., Pallivathukal S., Conzen P., Rehm M. Serum heparan sulfate levels are elevated in endotoxemia. Eur. J. Med. Res. 2009, 14:526-531.
22. Jacob M., Rehm M., Loetsch M., Paul J.O., Breugger D., Welsch U., Conzen P., Becker B.F. The endothelial glycocalyx prefers albumin for evoking shear stress-induced, nitric oxide-mediated coronary dilatation. J. Vasc. Res. 2007, 44:435-443.
23. Johansson P.I., Stensballe J., Rasmussen L.S., Ostrowski S.R. A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann. Surg. 2011, 254:194-200.
24. Ledin J., Staatz W., Li J., Götte M., Selleck S., Kjellén L., Spillmann D. Heparan sulfate structure in mice with genetically modified heparan sulfate production. J. Biol. Chem. 2004, 279(41):42732-42741.
25. Ley K., Bullard D.C., Arbonés M.L., Bosse R., Vestweber D., Tedder T.F., Beaudet A.L. Sequential contribution of L- and P-selectin to leukocyte rolling in vivo. J. Exp. Med. 1995, 181:669-675.
26. Long D.S., Smith M.L., Pries A.R., Ley K., Damiano E.R. Microviscometry reveals reduced blood viscosity and altered shear rate and shear stress profiles in microvessels after hemodilution. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:10060-10065.
27. Luft J.H. Fine structures of capillary and endocapillary layer as revealed by ruthenium red. Fed. Proc. 1966, 25:1773-1783.
28. Megens R.T., Reitsma S., Schiffers P.H., Hilgers R.H., De Mey J.G., Slaaf D.W., oude Egbrink M.G., van Zandvoort M.A. Two-photon microscopy of vital murine elastic and muscular arteries. Combined structural and functional imaging with subcellular resolution. J. Vasc. Res. 2007, 44:87-98.
29. Mulivor A.W., Lipowsky H.H. Role of glycocalyx in leukocyte-endothelial cell adhesion. Am. J. Physiol. 2002, 283:H1282-H1291.
30. Nieuwdorp M., Mooij H.L., Kroon J., Atasever B., Spaan J.A.E., Ince C., Holleman F., Diamant M., Heine R.J., Hoekstra J.B.L., Kastelein J.J.P., Stroes E.S.G., Vink H. Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes. Diabetes 2006, 55:1127-1132.
31. Park P.W., Pier G.B., Hinkes T.M., Bernfield M. Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence. Nature 2001, 411:98-102.
32. Park P.W., Foster T.J., Nishi E., Duncan S.J., Klagsbrun M. Activation of syndecan-1 ectodomain shedding by Staphylococcus aureus α-toxin and β-toxin. J. Biol. Chem. 2004, 279:251-258.
33. Platts S.H., Linden J., Duling B.R. Rapid modification of the glycocalyx caused by ischemia-reperfusion is inhibited by adenosine A2A receptor activation. Am. J. Physiol. 2003, 284:H2360-H2367.
34. Potter D.R., Damiano E.R. The hydrodynamically relevant endothelial cell glycocalyx observed in vivo is absent in vitro. Circ. Res. 2008, 102:770-776.
35. Potter D.R., Jiang J., Damiano E.R. The recovery time course of the endothelial glycocalyx in vivo and its implications in vitro. Circ. Res. 2009, 104:1318-1325.
36. Pries A.R., Secomb T.W., Jacobs H., Sperandio M., Osterloh K., Gaehtgens P. Microvascular blood flow resistance: role of endothelial surface layer. Am. J. Physiol. 1997, 273:H2272-H2279.
37. Pries A.R., Secomb T.W., Gaehtgens P. The endothelial surface layer. Pflugers Arch. 2000, 440:653-666.
38. Rehm M., Zahler S., Lötsch M., Welsch U., Conzen P., Jacob M., Becker B.F. Endothelial glycocalyx as an additional barrier determining extravasation of 6% hydroxyethyl starch or 5% albumin solutions in the coronary vascular bed. Anesthesiology 2004, 100:1211-1223.
39. Rehm M., Bruegger D., Christ F., Conzen P., Thiel M., Jacob M., Chappell D., Stoeckelhuber M., Welsch U., Reichart B., Peter K., Becker B.F. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation 2007, 116:1896-1906.
40. Rosenberg R.D., Shworak N.W., Liu J., Schwartz J.J., Zhang L. Heparan sulfate proteoglycans of the cardiovascular system. J. Clin. Invest. 1997, 99:2062-2070.
41. Savery M.D., Damiano E.R. The endothelial glycocalyx is hydrodynamically relevant in arterioles throughout the cardiac cycle. Biophys. J. 2008, 95:1439-1447.
42. Smith M.L., Long D.S., Damiano E.R., Ley K. Near-wall μ-PIV reveals a hydrodynamically relevant endothelial surface layer in venules in vivo. Biophys. J. 2003, 85:637-645.
43. Stanford K.I., Bishop J.R., Foley E.M., Gonzales J.C., Niesman I.R., Witztum J.L., Esko J.D. Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance in triglyceride-rich lipoproteins in mice. J. Clin. Invest. 2009, 119:3236-3245.
44. Stepp M.A., Gibson H.E., Gala P.H., Iglesia D.D.S., Pajoohesh-Ganji A., Pal-Ghosh S., Brown M., Aquino C., Schwartz A.M., Goldberger O., Hinkes M.T., Bernfield M. Defects in keratinocyte activation during wound healing in the syndecan-1-deficient mouse. J. Cell Sci. 2002, 115:4517-4531.
45. Steppan J., Hofer S., Funke B., Brenner T., Henrich M., Martin E., Weitz J., Hofmann U., Weigand M.A. Sepsis and major abdominal surgery lead to flaking of the endothelial glycocalix. J. Surg. Res. 2011, 165:136-141.
46. Stevens A.P., Hlady V., Dull R.O. Fluorescence correlation spectroscopy can probe albumin dynamics inside lung endothelial glycocalyx. Am. J. Physiol. 2007, 293:L328-L335.
47. Thi M.M., Tarbell J.M., Weinbaum S., Spray D.C. The role of the glycocalyx in reorganization of the actin cytoskeleton under fluid shear stress: a "bumper car" model. P. Natl. Acad. Sci. USA 2004, 101:16483-16488.
48. Van den Berg B.M., Vink H., Spaan J.A.E. The endothelial glycocalyx protects against myocardial edema. Circ. Res. 2003, 92:592-594.
49. Vink H., Duling B.R. Identification of distinct luminal domains for macromolecules, erythrocytes, and leukocytes within mammalian capillaries. Circ. Res. 1996, 79:581-589.
50. Weinbaum S., Tarbell J.M., Damiano E.R. The structure and function of the endothelial glycocalyx layer. Annu. Rev. Biomed. Eng. 2007, 9:121-167.
51. Zako M., Dong J., Goldberger O., Bernfield M., Gallagher J.T., Deakin J.A. Syndecan-1 and -4 synthesized simultaneously by mouse mammary gland epithelial cells bear heparan sulfate chains that are apparently structurally indistinguishable. J. Biol. Chem. 2003, 278:13561-13569.